Home › NDC Lookup › Ingredients › Cefdinir › 87063-0345-30
Cefdinir 300 mg Capsule, 30-count — NDC 87063-0345-30 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Cefdinir 300 mg Capsule, 30-count — NDC 87063-345-30 (Billing 87063-0345-30)

by ASCLEMED USA INC. · 30 CAPSULE in 1 BOTTLE

This is a package of 30 capsules of Cefdinir 300 mg Capsule from ASCLEMED USA INC., marketed since May 2007 and currently FDA-listed.

NDC 87063-0345-30
🏷️ FDA NDC (as labeled) 87063-345-30 billing pads the product segment with a zero
This package
Contains30-count Pack sizes4 compare ↓
Product page 87063-0345-01 Also comes in: 60 capsules 87063-345-60 90 capsules 87063-345-90 100 capsules 87063-345-01
Rx only Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 87063-345-30 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
87063 labeler · 345 product · 30 package
Package marketed since
Oct 3, 2026
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Barcode (UPC-A, from the NDC)
3 8706334530 0
FDA record last changed
Oct 8, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 87063-345-30
Product NDC 87063-345
11-digit billing NDC 87063034530
Application # ANDA065368
SPL Set ID 1805cb71-b33c-4b0b-8d01-45d7700ab9f4
Established class (EPC) Cephalosporin Antibacterial
Chemical class Cephalosporins
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2007-05-09
Route ORAL
Dosage form CAPSULE
Substance CEFDINIR
TE code (Orange Book) AB · RLD · RS
Why two NDCs? The FDA registers this code as 87063-345-30 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 87063-0345-30. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It treats mild to moderate bacterial infections such as pneumonia, sinus infections, strep throat, skin infections and, in children, ear infections. It will not help colds or the f...
  • No. You can take it with or without food. Try to take it at about the same times each day, and finish the full course even if you feel better.
  • It can be. Aluminum or magnesium antacids and iron supplements can lower how much cefdinir your body absorbs. Take cefdinir at least 2 hours before or after them.
  • I take an antacid or iron. Is that a problem?
📖 Read our full Cefdinir guide →
7
Nutrient depletion considerations

Cefdinir may be associated with lower levels of 7 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Cefdinir nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 60 capsules 90 capsules 100 capsules
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
87063-0345-01 87063-345-01 Main listing 100 CAPSULE in 1 BOTTLE 2026-10-03 — Active
87063-0345-30 You're viewing this 30 CAPSULE in 1 BOTTLE 2026-10-03 — Active
87063-0345-60 87063-345-60 60 CAPSULE in 1 BOTTLE 2026-10-03 — Active
87063-0345-90 87063-345-90 90 CAPSULE in 1 BOTTLE 2026-10-03 — Active

You're viewing the smallest of 4 pack sizes for this product.

Pack size FAQ

What quantity is in this package?
This is a 30-count package — 30 capsule in 1 bottle.
How does this package differ from NDC 87063-0345-60?
Both are Cefdinir 300 mg Capsule — the drug itself is identical. This page's package is the 30-count one, while NDC 87063-0345-60 is the 60 capsules package.
What NDC number is used to bill for this package of Cefdinir 300 mg Capsule?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Cefdinir 300 mg 68001-0362-06 BluePoint 60 capsules $0.458 AB Availability likely —
Cefdinir 300 mg 60687-0699-21 American 30 capsules $0.458 AB Availability likely —
Cefdinir 300 mg 00904-7563-04 Major 30 capsules $0.458 AB Availability likely —
Cefdinir 300 mg 68180-0711-60 Lupin 60 capsules $0.458 AB Availability likely —
Cefdinir 300 mg 57237-0099-60 Rising 60 capsules $0.458 AB Availability likely —
Cefdinir 300 mg 00093-3160-06 Teva 60 capsules $0.458 AB Availability likely —
Cefdinir 300 mg 00781-2176-01 Sandoz 100 capsules — AB FDA listed —
Cefdinir 300 mg 63187-0989-14 Proficient 14 capsules — AB FDA listed —
Cefdinir 300 mg 71205-0576-06 Proficient 6 capsules — AB FDA listed —
Cefdinir 300 mg 50090-2719-00 A-S 10 capsules — AB FDA listed —
Cefdinir 300 mg 50090-6041-00 A-S 10 capsules — AB FDA listed —
Cefdinir 300 mg 50090-6042-00 A-S 20 capsules — AB FDA listed —
Cefdinir 300 mg 71205-0224-14 Proficient 14 capsules — AB FDA listed —
Cefdinir 300 mg 82868-0059-20 Northwind 20 capsules — AB FDA listed —
Cefdinir 300 mg 50090-1033-00 A-S 10 capsules — AB FDA listed —
Cefdinir 300 mg 63629-8968-01 Bryant 20 capsules — AB FDA listed —
Cefdinir 300 mg 65862-0177-05 Aurobindo 500 capsules — AB FDA listed —
Cefdinir 300 mg 68071-3998-02 NuCare 2 capsules — AB FDA listed —
Cefdinir 300 mg 68788-8404-02 Preferred 20 capsules — AB FDA listed —
Cefdinir 300 mg 72189-0423-14 Direct_Rx 14 capsules — AB FDA listed —
Cefdinir 300 mg 72789-0054-14 PD-Rx 14 capsules — AB FDA listed —
Cefdinir 300 mg 43063-0959-20 PD-Rx 20 capsules — AB FDA listed —
Cefdinir 300 mg 68071-2503-02 NuCare 20 capsules — AB FDA listed —
Cefdinir 300 mg 70518-4169-00 REMEDYREPACK 20 capsules — AB FDA listed —
Cefdinir 300 mg 68788-8323-02 Preferred 20 capsules — AB FDA listed —
Cefdinir 300 mg 70518-1880-00 REMEDYREPACK 20 capsules — AB FDA listed —
Cefdinir 300 mg 68071-2401-02 NuCare 2 capsules — AB FDA listed —
Cefdinir 300 mg 42291-0043-60 AvKARE 60 capsules — AB FDA listed —
Cefdinir 300 mg 68071-4007-02 NuCare 20 capsules — AB FDA listed —
Cefdinir 300 mg 68071-4856-02 NuCare 20 capsules — AB FDA listed —
Cefdinir 300 mg 68788-7987-02 Preferred 20 capsules — AB FDA listed —
Cefdinir 300 mg 68071-5145-02 NuCare 20 capsules — AB FDA listed —
Cefdinir 300 mg 68788-7339-02 Preferred 20 capsules — AB FDA listed —
Cefdinir 300 mg 72789-0550-10 PD-Rx 10 capsules — AB FDA listed —
Cefdinir 300 mg 72789-0061-20 PD-Rx 20 capsules — AB FDA listed —
Cefdinir 300 mg 43063-0964-14 PD-Rx 14 capsules — AB FDA listed —
Cefdinir 300 mg 67877-0543-01 Ascend 100 capsules — AB FDA listed —
Cefdinir 300 mg 68071-4946-02 NuCare 2 capsules — AB FDA listed —
Cefdinir 300 mg 72189-0308-14 DirectRx 14 capsules — AB FDA listed —
Cefdinir 300 mg 63629-5101-01 Bryant 10 capsules — AB FDA listed —
Cefdinir 300 mg 67296-1448-07 Redpharm 14 capsules — AB Discontinued —
Cefdinir 300 mgthis 87063-0345-30 ASCLEMED 30 capsules — AB FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2007
On the market since
May 2007
📍
2026
Currently FDA-listed
19 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color green / purple
ShapeCapsule
Imprint93;3160;93;3160
Size23 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Cefdinir inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII UTY7PDF93L
    A plant-derived thickening agent made from cellulose. It acts as a binder to hold tablet ingredients together and as a disintegrant to help the tablet break apart in your stomach so the medicine can be absorbed.
  • UNII M28OL1HH48
    Croscarmellose sodium is a plant-based substance derived from cellulose. It acts as a disintegrant, helping tablets and capsules break down quickly in the digestive system so the medicine can be absorbed.
  • UNII 767IP0Y5NH
    A synthetic red colorant used to give medicines their color. It helps patients identify their medication and makes the product visually appealing.
  • UNII 35SW5USQ3G
    A synthetic yellow dye used to color medicines. It helps make tablets, capsules, and liquids visually distinct so patients can easily identify their medication.
  • UNII CQ3XH3DET6
    D&C Yellow No. 10 Aluminum Lake is a yellow colorant made by combining a dye with aluminum salts. It's used in medicines to add color for product identification and visual appeal.
  • UNII H3R47K3TBD
    FD&C Blue No. 1 is a synthetic blue dye approved for use in foods and medicines. It serves as a colorant to give the medication its distinctive appearance and help with product identification.
  • UNII J9EQA3S2JM
    FD&C Blue No. 1 Aluminum Lake is a blue colorant made by combining FD&C Blue No. 1 dye with aluminum salts. It is used to color tablets, capsules, and other medicines for easy identification and appearance.
  • UNII 4AQJ3LG584
    A synthetic blue dye combined with aluminum to create a stable colorant. It's used in medicines and supplements to add blue color or create specific shades for product identification and appearance.
  • UNII 3P3ONR6O1S
    A synthetic green dye approved by the FDA for use in medicines and foods. It serves as a colorant to make the pill or liquid visually distinctive and help with product identification.
  • UNII WZB9127XOA
    A synthetic red dye used to color medications and make them easier to identify. It serves as a colorant in tablets, capsules, and liquid formulations.
  • UNII XM0M87F357
    A dark iron oxide compound that gives medicines their black or dark color. It's used as a colorant in tablets and capsules to help identify the product and make it visually distinctive.
  • UNII 2G86QN327L
    Gelatin is a protein derived from animal collagen, commonly used in medicines as a gelling agent and capsule material. It helps create soft or hard capsule shells that hold and release medication, and can also thicken liquid formulations.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 13A4J4NH9I
    A synthetic emulsifier derived from stearic acid and polyethylene glycol. It helps mix oil and water-based ingredients together in liquid medicines and creams to create a smooth, uniform product.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII 46N107B71O
    Shellac is a natural resin secreted by the lac beetle. It's used as a coating on tablets and capsules to control how quickly the medicine dissolves and to improve appearance and stability.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII 368GB5141J
    A detergent and foaming agent derived from coconut or palm oil. In medications, it helps break down and mix oil and water-based ingredients, aids in tablet disintegration, and improves how the drug dissolves and spreads in the mouth or digestive system.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.

19 inactive ingredients listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerASCLEMED USA INC.
Application holderTEVA PHARMACEUTICALS USA
FDA applicationANDA065368 (ANDA)
Labeler code87063
First marketedMay 2007
Product typeHuman Prescription Drug
Portfolio136 products on file

More NDCs from ASCLEMED USA INC. labeler code 87063

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Cefdinir — the program that covers self-administered drugs. 8 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Cefdinir. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$8.13M
Claims incl. refills
582.9K
Beneficiaries
534.9K
Spend / beneficiary
$15.20
Spend / claim
$13.95
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

About this NDC listing & data coverage

Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data ✓ Available
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by ASCLEMED USA INC.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 3 other package presentations of this same product, including 60 capsules (87063-0345-60), 90 capsules (87063-0345-90), 100 capsules (87063-0345-01). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
ASCLEMED USA INC. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 87063-0344-30 · ASCLEMED 87063-0686-12 · ASCLEMED →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.